- Home
- ASH vs XENE Comparison
ASH vs XENE Comparison
Compare ASH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASH
- XENE
- Stock Information
- Founded
- ASH 1924
- XENE 1996
- Country
- ASH United States
- XENE Canada
- Employees
- ASH N/A
- XENE N/A
- Industry
- ASH Specialty Chemicals
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- ASH Consumer Discretionary
- XENE Health Care
- Exchange
- ASH Nasdaq
- XENE Nasdaq
- Market Cap
- ASH 2.4B
- XENE 2.3B
- IPO Year
- ASH N/A
- XENE 2014
- Fundamental
- Price
- ASH $49.76
- XENE $30.72
- Analyst Decision
- ASH Buy
- XENE Strong Buy
- Analyst Count
- ASH 5
- XENE 11
- Target Price
- ASH $70.75
- XENE $54.82
- AVG Volume (30 Days)
- ASH 542.6K
- XENE 1.5M
- Earning Date
- ASH 04-30-2025
- XENE 05-12-2025
- Dividend Yield
- ASH 3.33%
- XENE N/A
- EPS Growth
- ASH N/A
- XENE N/A
- EPS
- ASH N/A
- XENE N/A
- Revenue
- ASH $1,949,000,000.00
- XENE $7,500,000.00
- Revenue This Year
- ASH N/A
- XENE N/A
- Revenue Next Year
- ASH $2.30
- XENE $611.23
- P/E Ratio
- ASH N/A
- XENE N/A
- Revenue Growth
- ASH N/A
- XENE N/A
- 52 Week Low
- ASH $45.21
- XENE $26.74
- 52 Week High
- ASH $102.50
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- ASH 46.17
- XENE 44.84
- Support Level
- ASH $48.81
- XENE $28.19
- Resistance Level
- ASH $50.99
- XENE $31.74
- Average True Range (ATR)
- ASH 1.20
- XENE 1.13
- MACD
- ASH -0.06
- XENE -0.01
- Stochastic Oscillator
- ASH 37.66
- XENE 71.27
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.